HTG Molecular Diagnostics Price Prediction
HTGMDelisted Stock | USD 0.57 0.20 54.05% |
Oversold Vs Overbought
30
Oversold | Overbought |
Using HTG Molecular hype-based prediction, you can estimate the value of HTG Molecular Diagnostics from the perspective of HTG Molecular response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in HTG Molecular to buy its stock at a price that has no basis in reality. In that case, they are not buying HTG because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
HTG Molecular after-hype prediction price | USD 0.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
HTG |
HTG Molecular After-Hype Price Prediction Density Analysis
As far as predicting the price of HTG Molecular at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in HTG Molecular or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of HTG Molecular, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
HTG Molecular Estimiated After-Hype Price Volatility
In the context of predicting HTG Molecular's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on HTG Molecular's historical news coverage. HTG Molecular's after-hype downside and upside margins for the prediction period are 0.57 and 0.57, respectively. We have considered HTG Molecular's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
HTG Molecular is very steady at this time. Analysis and calculation of next after-hype price of HTG Molecular Diagnostics is based on 3 months time horizon.
HTG Molecular Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as HTG Molecular is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading HTG Molecular backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with HTG Molecular, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 7 Events / Month | 6 Events / Month | In about 7 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.57 | 0.57 | 0.00 |
|
HTG Molecular Hype Timeline
HTG Molecular Diagnostics is currently traded for 0.57. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. HTG is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on HTG Molecular is about 0.0%, with the expected price after the next announcement by competition of 0.57. The company recorded a loss per share of 17.1. HTG Molecular Diagnostics last dividend was issued on the 23rd of November 2020. The entity had 1:12 split on the 21st of December 2022. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.HTG Molecular Related Hype Analysis
Having access to credible news sources related to HTG Molecular's direct competition is more important than ever and may enhance your ability to predict HTG Molecular's future price movements. Getting to know how HTG Molecular's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how HTG Molecular may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
GTH | Genetron Holdings | (0.02) | 1 per month | 2.49 | (0.04) | 3.45 | (4.08) | 14.43 | |
BIAF | bioAffinity Technologies, | 0.19 | 7 per month | 0.00 | (0.04) | 10.10 | (7.33) | 61.86 | |
PMD | Psychemedics | 0.01 | 6 per month | 0.53 | (0.19) | 0.87 | (0.87) | 3.46 | |
PRPO | Precipio | (0.21) | 7 per month | 0.00 | (0.06) | 4.20 | (3.88) | 11.81 | |
INBS | Intelligent Bio Solutions | (0.07) | 10 per month | 6.12 | 0.06 | 13.16 | (10.59) | 40.29 | |
BIAFW | bioAffinity Technologies Warrant | (0.06) | 2 per month | 12.55 | 0 | 28.21 | (26.44) | 96.67 | |
SQL | SeqLL Inc | 0.01 | 1 per month | 4.49 | (0) | 12.50 | (10.64) | 50.87 | |
IDXG | Interpace Biosciences | 0.00 | 0 per month | 9.49 | 0.12 | 18.81 | (16.19) | 194.90 | |
BIOC | Biocept | (0.10) | 3 per month | 0.00 | (0.29) | 9.24 | (15.27) | 66.54 | |
TTOO | T2 Biosystms | (0.03) | 7 per month | 0.00 | (0.42) | 6.19 | (12.50) | 26.00 | |
GENE | Genetic Technologies | 0.02 | 4 per month | 0.00 | (0.22) | 2.63 | (3.53) | 8.88 |
HTG Molecular Additional Predictive Modules
Most predictive techniques to examine HTG price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for HTG using various technical indicators. When you analyze HTG charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About HTG Molecular Predictive Indicators
The successful prediction of HTG Molecular stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as HTG Molecular Diagnostics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of HTG Molecular based on analysis of HTG Molecular hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to HTG Molecular's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to HTG Molecular's related companies.
Story Coverage note for HTG Molecular
The number of cover stories for HTG Molecular depends on current market conditions and HTG Molecular's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that HTG Molecular is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about HTG Molecular's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
HTG Molecular Short Properties
HTG Molecular's future price predictability will typically decrease when HTG Molecular's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of HTG Molecular Diagnostics often depends not only on the future outlook of the potential HTG Molecular's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. HTG Molecular's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 889.3 K | |
Cash And Short Term Investments | 12.2 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in HTG Stock
If you are still planning to invest in HTG Molecular Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the HTG Molecular's history and understand the potential risks before investing.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Global Correlations Find global opportunities by holding instruments from different markets |